EP Wealth Advisors LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 13,155 shares of the conglomerate's stock, valued at approximately $9,472,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Main Street Group LTD purchased a new stake in Danaher in the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the 2nd quarter valued at $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter worth $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher in the fourth quarter worth $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Stock Up 1.6%
DHR stock opened at $219.42 on Friday. The firm has a market cap of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a fifty day simple moving average of $195.80 and a 200 day simple moving average of $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the business posted $0.77 earnings per share. The business's quarterly revenue was up 5.5% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on DHR shares. Wall Street Zen cut Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, April 25th. Wolfe Research lowered Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Finally, Evercore reissued an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $228.91.
View Our Latest Report on DHR
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
